跳至主要内容
临床试验/NCT01174524
NCT01174524已完成4 期

Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of Menacme

Hospital Geral de Fortaleza1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2008年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
100
试验地点
1
主要终点
Quality of life

研究概览

简要总结

The purpose of this study is to determine whether low-dose contraceptive pills are effective in the improvement of quality of life in patients in the different phases of menacme.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 46 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Fertile women with indication of use of contraceptive pills

排除标准

  • Fertile women with any surgical contraceptive method
  • Women in menopause
  • Diseases the forbidden the use of the drug

研究组 & 干预措施

gestoden and ethinylestradiol

Experimental

Gestoden 60 mcg plus ethinylestradiol 15 mcg, once a day, administered in 24∕4 regimen, for three months.

The use of gestoden and ethinylestradiol can do an improvement of the quality of life before and after the use of the drug.Numerous large clinical trials have shown that this combination is as effective in preventing pregnancies as other oral contraceptives presently on the market. Irregular bleeding and spotting rates appear to be at least as good as older formulations. In general, the incidence of side effects associated with the progestin and estrogen components tends to be low, with very little impact on lipid and carbohydrate metabolism. . For this, the regimen can ameliorate the quality of life of the patients.

干预措施: gestoden 60 mcg (Drug)

gestoden and ethinylestradiol

Experimental

Gestoden 60 mcg plus ethinylestradiol 15 mcg, once a day, administered in 24∕4 regimen, for three months.

The use of gestoden and ethinylestradiol can do an improvement of the quality of life before and after the use of the drug.Numerous large clinical trials have shown that this combination is as effective in preventing pregnancies as other oral contraceptives presently on the market. Irregular bleeding and spotting rates appear to be at least as good as older formulations. In general, the incidence of side effects associated with the progestin and estrogen components tends to be low, with very little impact on lipid and carbohydrate metabolism. . For this, the regimen can ameliorate the quality of life of the patients.

干预措施: ethinylestradiol 15 mcg (Drug)

结局指标

主要结局

Quality of life

时间窗: eleven months

次要结局

  • Quality of life in differents phases of menacme(eleven months)

研究者

申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验